Regenxbio names George Migausky board chairman
RGNX•Regenxbio appointed independent director George Migausky as board chairman after director Kenneth T. Mills resigned, effective October 21, 2026; Daniel Tassé stepped down as lead independent director.
1. Board leadership changes
Regenxbio director Kenneth T. Mills resigned on October 14, 2026, effective October 21. The board appointed independent director George Migausky as chairman in connection with Mills’ departure, and Daniel Tassé stepped down as lead independent director because the new chairman is independent.
